First Rounders: Grace Colón
Published in Bioengineering & Biotechnology

The most recent guest on First Rounders is Grace Colón, president and CEO of InCarda Therapeutics. She did her graduate work at MIT, where she was mentored by Greg Stephanopoulos and Anthony Sinskey, and then went to work at McKinsey & Co. That began her career path toward biotech, including stints at Affymetrix (later bought by Thermo Fisher), and Gilead Sciences (currently doing its part against covid19).
She also has experience in venture capital, having been with New Science Ventures. The podcast can be found here.
Follow the Topic
-
Nature Biotechnology
A monthly journal covering the science and business of biotechnology, with new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences.
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in